We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App




Events

03 Feb 2020 - 06 Feb 2020
01 Mar 2020 - 05 Mar 2020

Industry News

Image: BioProfile FLEX2 On-Line Autosampler (Photo courtesy of Nova Biomedical)

Nova Biomedical Launches New BioProfile FLEX2 On-Line Autosampler

 Nova Biomedical (Waltham, MA, USA) has launched the BioProfile FLEX2 On-Line Autosampler (OLS), a modular system that connects as many as 10 bioreactors to one FLEX2 analyzer for up to three weeks of walkaway, automated sampling, analysis, and feedback control of key cell culture analytes. The FLEX2 measures up to 16 tests, including pH, gases, metabolites, osmolality, cell density, and cell viability. More...
03 Jan 2020
Image: Analyticon Coagulyzer 100 (Photo courtesy of Analyticon)

Global Hematology Diagnostic Devices and Equipment Market to Reach USD 2.35 Billion by 2022

 The global hematology diagnostic devices and equipment market was valued at about USD 1.9 billion in 2018 and is projected to grow to at a CAGR of 5.5% to USD 2.35 billion in 2022. The market growth is driven mainly by an increase in the use of hematology diagnostic devices due to the rising prevalence of blood disorders which affect millions of people each year across the world, irrespective of age, race, and sex. More...
03 Jan 2020
Illustration

AI-based Software Analyzes Cancer Cells from Digitized Pathology Slides to Improve Diagnoses

 Researchers from UT Southwestern (Dallas, TX, USA) have developed a software tool that uses artificial intelligence (AI) to recognize cancer cells from digital pathology images, allowing clinicians to predict patient outcomes. More...
31 Dec 2019
Image: Global Lateral Flow Immunoassay based Rapid Test Market is expected to reach $8,494 million by 2026 (Photo courtesy of Allied Market Research)

Global Lateral Flow Immunoassay Based Rapid Test Market to Reach USD 8.49 Billion by 2026

 The global lateral flow immunoassay (LFIA) based rapid test market was estimated to be worth USD 4.72 billion in 2018 and is expected to grow at a CAGR of 7.6% from 2019 to 2026 to reach USD 8.49 billion by 2026. The market growth will be driven by the benefits of LFIA-based rapid tests over laboratory testing, increasing initiatives by government and non-profit organizations for improving health awareness, and rising healthcare expenditure globally. On the other hand, the market growth will be hampered to some extent by inadequate reimbursement policies for LFIA-based rapid test diagnostics. Nevertheless, the growth prospects in the emerging markets and a surge in various chronic and infectious diseases across the world are expected to create significant opportunities for the key players in the industry. More...
24 Dec 2019
Illustration

Mast Group Launches MAST ISOPLEX CRE-Art Kit for Rapid Molecular Detection of Carbapenemase Producing Organisms

 Mast Group Ltd. (Liverpool, UK) announced the expansion of its molecular product portfolio with the launch of the new MAST ISOPLEX CRE-ART kit for the rapid molecular detection of carbapenemase producing organisms (CPOs). More...
23 Dec 2019
Image: The Bench Top segment is the biggest driver to the global blood gas and electrolyte analyzers market (Photo courtesy of Market Research Business).

Global Blood Gas and Electrolyte Analyzers Market to Surpass USD 2.1 Billion by 2025

The global blood gas and electrolyte analyzers market is projected to grow at a CAGR of 6.5% during the forecast period, 2018-2025 to reach a value of over USD 2.1 billion by 2025, driven mainly by the Bench Top segment which is anticipated to bring in healthy gains and add significant momentum to the market growth. The Bench Top segment is projected to grow at a CAGR of over 6.4% during the forecast period. More...
06 Nov 2019
Image: In 2019, lab-on-a-chip/microfluidic diagnostics is expected to grow at the fastest CAGR, owing to its capability for scaling down whole lab processes on a single chip and expediting the process of disease diagnosis with highly precise quantitative results (Photo courtesy of Fotolia).

Global Microfluidic Immunoassay Market to Reach USD 2 Billion by 2025

The global microfluidic immunoassay market is expected to grow at a CAGR of 12.7% from 2019 to USD 2.0 billion by 2025, driven by greater benefits offered by Lab-on-chip (LOC) over conventional quantifiable technologies, the growing need for point-of-care (POC) in low-resource settings, and increasing research activities in the field of microfluidic technology. More...
01 Oct 2019


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2020 Globetech Media. All rights reserved.